Free Trial

SPDR S&P Biotech ETF (XBI) News Today

SPDR S&P Biotech ETF logo
$130.69 -4.16 (-3.08%)
As of 05/15/2026 04:10 PM Eastern

XBI Latest News

Assorted pharmaceutical pills, a medicine vial, and a syringe arranged on a laboratory bench.
2 Ways to Play the Big Pharma Patent Cliff
With hundreds of billions in sales on the line for drugs that will lose their patent exclusivity in the coming years, two biotech ETFs can help capitalize.
Biotech stocks are among today's winners
Funding for Risky Biotechs Is Returning
Biotech: Time For A Pause To Start 2026
2 Brilliant Biotech ETFs to Watch in 2026
State Street® SPDR® S&P® Biotech ETF
XBI: Biotech Funding Condition Recovery Could Be Overdue
Daily ETF Flows: Biotech ETF 'XBI' In Demand
Why Biotech’s Rally Can Last This Time
4 Biotech Stocks Seeing Explosive Momentum Gains
3 Reasons To Be Optimistic Around Biotech In Q4
XBI: Surprise Exit Of A Tough Regulator At The FDA
SPDR S&P Biotech ETF (XBI) - Yahoo Finance
XBI Chart | SPDR S&P Biotech ETF - Investing.com
SPDR S&P Biotech ETF Experiences Big Inflow
Friday's ETF Movers: XBI, COPX
Invest In A New Biotech Bull Market With XBI And IBB
SPDR S&P Dividend ETF (SDY): How to Buy
XBI: Diverse Holding Amid Strong Catalysts, Buy
3 Biotech Stocks With Notable Insider Buying
Get SPDR S&P Biotech ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XBI Media Mentions By Week

XBI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XBI
News Sentiment

0.68

0.55

Average

News Sentiment

XBI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XBI Articles
This Week

1

0

XBI Articles
Average Week

Get the Latest News and Ratings for XBI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for SPDR S&P Biotech ETF and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NYSEARCA:XBI) was last updated on 5/17/2026 by MarketBeat.com Staff.
From Our Partners